share_log

Everjoy Health Group's (SZSE:002162) Performance Is Even Better Than Its Earnings Suggest

Everjoy Health Group's (SZSE:002162) Performance Is Even Better Than Its Earnings Suggest

Everjoy Health Group(深圳证券交易所:002162)的表现甚至好于其收益预期
Simply Wall St ·  05/02 18:26

The subdued stock price reaction suggests that Everjoy Health Group Co., Ltd.'s (SZSE:002162) strong earnings didn't offer any surprises. We think that investors have missed some encouraging factors underlying the profit figures.

疲软的股价反应表明,Everjoy Health Group Co., Ltd.s(深圳证券交易所:002162)强劲的收益并没有带来任何意外。我们认为,投资者错过了利润数据背后的一些令人鼓舞的因素。

earnings-and-revenue-history
SZSE:002162 Earnings and Revenue History May 2nd 2024
SZSE: 002162 收益和收入历史记录 2024 年 5 月 2 日

How Do Unusual Items Influence Profit?

不寻常的物品如何影响利润?

To properly understand Everjoy Health Group's profit results, we need to consider the CN¥15m expense attributed to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's hardly a surprise given these line items are considered unusual. Assuming those unusual expenses don't come up again, we'd therefore expect Everjoy Health Group to produce a higher profit next year, all else being equal.

为了正确了解Everjoy Health Group的利润业绩,我们需要考虑因不寻常项目而产生的1500万元人民币支出。尽管由于不寻常项目而产生的扣除首先令人失望,但有一线希望。当我们分析全球绝大多数上市公司时,我们发现重大不寻常的事项往往不会重演。鉴于这些单列项目被认为不寻常,这并不奇怪。假设这些不寻常的支出不会再次出现,因此,我们预计Everjoy Health Group在其他条件相同的情况下,明年将实现更高的利润。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Everjoy Health Group.

注意:我们始终建议投资者检查资产负债表的实力。点击此处查看我们对Everjoy Health Group的资产负债表分析。

Our Take On Everjoy Health Group's Profit Performance

我们对Everjoy Health 集团盈利表现的看法

Because unusual items detracted from Everjoy Health Group's earnings over the last year, you could argue that we can expect an improved result in the current quarter. Because of this, we think Everjoy Health Group's earnings potential is at least as good as it seems, and maybe even better! And it's also positive that the company showed enough improvement to book a profit this year, after losing money last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. For example, we've found that Everjoy Health Group has 2 warning signs (1 can't be ignored!) that deserve your attention before going any further with your analysis.

由于不寻常的项目削弱了Everjoy Health Group去年的收益,你可能会争辩说,我们可以预期本季度的业绩会有所改善。因此,我们认为Everjoy Health Group的盈利潜力至少和看起来一样好,甚至可能更好!在去年亏损之后,该公司表现出了足够的改善,今年实现了盈利,这也是一个积极的因素。归根结底,如果你想正确地了解公司,必须考虑的不仅仅是上述因素。有鉴于此,如果你想对公司进行更多分析,了解所涉及的风险至关重要。例如,我们发现 Everjoy Health Group 有 2 个警告信号(1 个不容忽视!)在进行进一步分析之前,这值得你注意。

Today we've zoomed in on a single data point to better understand the nature of Everjoy Health Group's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

今天,我们放大了单个数据点,以更好地了解Everjoy Health Group利润的性质。但是,如果你能够将注意力集中在细节上,总会有更多的事情需要发现。例如,许多人认为高股本回报率是有利的商业经济的标志,而另一些人则喜欢 “关注资金”,寻找内部人士正在买入的股票。因此,你可能希望看到这份免费收藏的拥有高股本回报率的公司,或者这份内部人士正在购买的股票清单。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发